DADC
DMK

D.A. Davidson & Co’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

D.A. Davidson & Co’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11
Closed -$4K – 2072
2017
Q2 		$4K Buy
+11
New +$3.29K ﹤0.01% 2243

Other funds holding DMK

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
LCM
Leisure Capital Management Costa Mesa, California $286M AUM 26.75% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

D.A. Davidson & Co's DMK Position: Q3 2017 in Review

D.A. Davidson & Co sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q3 2017, closing a stake of 11 shares — an estimated $4K sold.

D.A. Davidson & Co first reported a position in DMK in Q2 2017 and held it in 1 quarter. The position peaked at $4K in Q2 2017. 46 funds tracked by Wall St. Rank hold DMK as of Q3 2017.

  • D.A. Davidson & Co reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q3 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 11 DMK Pharmaceuticals Corporation Common Stock shares in Q3 2017, an estimated $4K.
  • D.A. Davidson & Co first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2017 and held it in 1 quarter.
  • D.A. Davidson & Co's DMK Pharmaceuticals Corporation Common Stock position peaked at $4K in Q2 2017.
  • 46 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.